¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõ½ÀÁø Ä¡·á °ÆÁ¤³¡

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 
#ÀÎõ½ÀÁø, #ÀÎõ½ÀÁøÄ¡·á, #È­Æó»óÇǺο°, #ÀÎõȭÆó»óÇǺο°, #½ÀÁøÄ¡·á, #È­Æó»óÇǺο°Ä¡·á, #ÀÎõȭÆó»óÇǺο°, #µ¿Ãᵿ½ÀÁø ÀÎõ½ÀÁø,,ÀÎõ½ÀÁøÄ¡·á,,È­Æó»óÇǺο°,,ÀÎõȭÆó»óÇǺο°,,½ÀÁøÄ¡·á,,È­Æó»óÇǺο°Ä¡·á,,ÀÎõȭÆó»óÇǺο°,,µ¿Ãᵿ½ÀÁø ¾È³çÇϼ¼¿ä. ÀÎõ½ÀÁø µ¿Ãᵿ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä ÀÎõ½ÀÁø µ¿Ãᵿ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ÀÎõÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´ÂÈ­Æó»óÇǺο°, ¸¸¼º½ÀÁø, ½ÀÁø°¡·Á¿ò, ÁֺνÀÁø, È­Æó»ó½ÀÁøÇǺΰú, ÇǺνÀÁø, ¹ß°¡¶ô»çÀ̽ÀÁø, À¯µÎ½ÀÁø, µ¿Àü½ÀÁø, »çŸ±¸´Ï½ÀÁø, ¹ß½ÀÁø, ½ÀÁøÄ¡·á, ¼Õ½ÀÁø, ¾ó±¼½ÀÁø, ½ÀÁø, ¾ó±¼È­Æó»ó½ÀÁø, ¹ß°¡¶ô½ÀÁø, ½ÀÁøÇÑÀÇ¿ø, ½ÀÁøÇǺΰú, Àü½Å½ÀÁø, ´Ù¸®½ÀÁø, È­Æó½ÀÁø, È­Æó»ó½ÀÁø, ¼Õ°¡¶ô½ÀÁø, ¾Æ±âÇǺνÀÁøµî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó °æ±ÙÃß³ª¿ä¹ý, Áß¼º¾îÇ÷¾àħ, ÅëÁõÄ¡·á±â, ¾ÆÀ̽ºÆÑ, ÅÙ½º, ÀÌ¿ÂÀüÀÚÀڱؿä¹ý, °æÇÇ°æ±Ù¿Â¿­¿ä¹ý, ¾óÀ½ÆÑ, ¿äÃß°ßÀÎÄ¡·á, º¹Àâ¿îµ¿Ä¡·á, ±Ù·Â¼öÇàÆò°¡, ±¤¿ªµ¿¿ä¹ý, Çâ±âÀÚ°¡¿ä¹ý, ÇÁ·Ñ·ÎÅ׶óÇÇ, Àåħ, ±¤¼±¿ä¹ý, ü¿­Áø´Ü(Àü½Å), acuatic therapy, ½ÉºÎ¿­Ä¡·á, ¾îÇ÷¾àħ, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç °æ±â ½ÃÈï½Ã Á¶³²µ¿, ÀÎõ ³²±¸ ¼þÀÇ1.3µ¿, ÃæºÏ ¿µµ¿±º Ãßdz·É¸é, ºÎ»ê ³²±¸ ¿ëÈ£3µ¿, °æ±â °¡Æò±º »ó¸é, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ µÎ¿ùµ¿2°¡, °æ±â ¾È¼º½Ã ¹Ì¾ç¸é, ÀüºÏ ³²¿ø½Ã ´ö°ú¸é, Àü³² ¹«¾È±º ÇØÁ¦¸é, ÀÎõ Áß±¸ Á߻굿, Á¦ÁÖ Á¦Áֽà °ÇÀÔµ¿, °æºÏ °æ»ê½Ã Á¤Æòµ¿, °æ±â ½ÃÈï½Ã Æ÷µ¿, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¼­¾È¾ç¿ìü±¹»ç¼­ÇÔ, °­¿ø ¾ç¾ç±º ¾ç¾çÀ¾, °æ±â ¾çÁֽà ¿ÁÁ¤µ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ ¿Àµ¿µ¿, Ãæ³² ´çÁø½Ã ¸éõ¸é, °æ³² â¿ø½Ã ¼º»ê±¸ â¿ø¿ìü±¹»ç¼­ÇÔ, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ °¡Æ÷µ¿, °æ³² Çϵ¿±º ±Ý¼º¸é, ÀÎõ ¿¬¼ö±¸ µ¿Ãᵿ, ºÎ»ê »ç»ó±¸ ÁÖ·Ê3µ¿, °æ³² ±èÇؽà ºÀȲµ¿, °æ±â Àǿսà ³»¼Õ2µ¿, ÀüºÏ ³²¿ø½Ã ´ë°­¸é, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ È«¹®µ¿, °æ±â ±ºÆ÷½Ã ±ºÆ÷2µ¿, Àü³² ³ªÁֽà ûµ¿, °­¿ø »ïô½Ã ±Ù»êµ¿, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù ÀÎõ½ÀÁøÄ¡·á ãÀ¸½Ã´Â ¿¬¼ö±¸, ¼þÀǵ¿, °Ë´Ü, ¹è°ð, ¼Ò·¡Æ÷±¸, °£¼®µ¿, Á־ȿª, °ü±³µ¿, ¸¶µµ¸é, ¼Û»ê¸é, Á¤¿Õµ¿, ¿î³²µ¿, °è¾ç±¸, ¿ëÇöµ¿, ÀÎõÁÖ¾È, ºÀ´ãÀ¾, À²¸ñµ¿, ÇÐÀ͵¿, ½ÃÈ­, ûÇе¿, ÆÈź¸é, ¿¬¼öµ¿, ÀÎõ, ³²¾çÀ¾, °¡Áµ¿, ºÎõ, ³²µ¿±¸, ÀÎõ³íÇö, ¿µÁ¾µµ, µ¿±¸, ¸Å¼Û¸é, ÀÛÀüµ¿, ¼±Çе¿, ½ÃÈï, °¡Á¤µ¿ µî ÀÎõ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿øÀÎõÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. Margolis DJ, Hoffstad O, Bilker W. Lack of association between exposure to topical calcineurin inhibitors and skin cancer in adults. Dermatology 2007; 214:289. 2. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 4:1. 3. Malajian D, Belsito DV. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis. J Am Acad Dermatol 2013; 69:232. 4. Saleem MD, Oussedik E, D'Amber V, Feldman SR. Interleukin-31 Pathway and its Role in Atopic Dermatitis: A Systematic Review. J Dermatolog Treat 2017; :1. 5. Totté JE, van der Feltz WT, Hennekam M, et al. Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol 2016; 175:687. 6. www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/207695Orig1s000ltr.pdf (Accessed on December 20, 2016). 7. Bonnel RA, La Grenade L, Karwoski CB, Beitz JG. Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experience. J Am Acad Dermatol 2003; 48:294. 8. Cabana MD, McKean M, Caughey AB, et al. Early Probiotic Supplementation for Eczema and Asthma Prevention: A Randomized Controlled Trial. Pediatrics 2017; 140. 9. Kong HH, Oh J, Deming C, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 2012; 22:850. 10. Bath-Hextall FJ, Birnie AJ, Ravenscroft JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review. Br J Dermatol 2010; 163:12.
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõ½ÀÁø Ä¡·á °ÆÁ¤³¡""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀÎõÀý¹ÚÀ¯»ê ÇÑÀÇ¿ø ÁÖ¸»Áø·á
´ÙÀ½±Û ÀÎõ¸ð°ø°¢È­Áõ Ä¡·á µµ¿òÀ»
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
952 ´ÙÀ̾îÆ®ÇÑÀÇ¿ø »õÇØ À̺¥Æ® ÁøÇà ´ÙÀ̾îÆ®ÇÑ¾à ±¸ÀÔ Æ÷ÀÎÆ® Á¦°ø 0 95 2024-01-15
951 ÀÌõ±³Åë»ç°íÇÑÀÇ¿ø Ãʱ⠰ü¸®·Î ÈÄÀ¯Áõ ¿¹¹æÇØ¿ä 3 317 2023-10-14
950 ÆíµÎÅë ¿¹¹æ¾à ó¹æ, ÁøÅëÁ¦¿Í ÇѾà Ä¡·á ¾Ë¾Æº¸±â 0 319 2023-10-13
949 ¸Þ´Ï¿¡¸£º´ Áø´Ü ¹Þ¾Ò´Ù¸é ¾çÀç µÎûÇÑÀÇ¿øÀ¸·Î 0 341 2023-10-13
948 »êº»±³Åë»ç°íÇÑÀÇ¿ø Ä¡·á¸¸Á·µµ ³ôÀº ÀÌÀ¯ 0 520 2023-08-18
947 â¿ø ÇѾàÀßÁþ´Â°÷ À¯¾Ø¹ÌÇÑÀÇ¿ø 2 806 2023-06-02
946 [ÆíµÎÅëÄ®·³2ź]µÎûÇÑÀÇ¿ø, ÆíµÎÅëÀÌ Ä¡·á°¡ ¾ÈµÇ´Â ÀÌÀ¯ 0 632 2023-05-23
945 [ÆíµÎÅëÄ®·³1ź]µÎûÇÑÀÇ¿ø, ÆíµÎÅëÀ» ¾Î´ø ÇÑÀÇ»ç ÆíµÎÅëÀ» ¿ÏÄ¡ÇÏ´Ù 3 665 2023-05-19
944 â¿ø ¸¶»ê ´ß»ìÇǺΠ¸ð°ø°¢È­Áõ ÇÑÀÇ¿ø Ä¡·á·Î ½Î¾Ç~ 2 654 2023-05-11
943 ºÎ»ê¼­¸é´ÙÀ̾îÆ®ÇÑÀÇ¿ø »ýÈ°°Ç°­ÇÑÀÇ¿ø 5¿ù °¡Á¤ÀÇ´Þ Æ¯°¡À̺¥Æ® ½ÃÀÛ.. 3 875 2023-05-10
942 ±¸¿ùµ¿ÇÑÀÇ¿ø °æÈñÀÚ¶õÇÑÀÇ¿ø¿¡¼­ ´ÙÀ̾îÆ® ±³Åë»ç°í Ãß³ª¿ä¹ý ÀÎõ ³².. 2 805 2023-05-10
941 â¿ø´ÙÀ̾îÆ®ÇÑÀÇ¿ø, â¿ø´ÙÀ̾îƮȯ À¯¾Ø¹ÌÇÑÀÇ¿ø ½½¸²È¯ 2 792 2023-04-20
940 ûÁÖ º¹´ëµ¿ ÇÑÀÇ¿ø, ¸¶À½¿¡²ÉÇÑÀÇ¿ø º½¸ÂÀÌ À̺¥Æ® 18 884 2023-04-19
939 ¿µµîÆ÷ÇÑÀÇ¿ø ¼±ÇÑÀÇ¿ø Áñ°Å¿ö º½ À̺¥Æ® 14 778 2023-04-19
938 â¿ø ¸¶»ê ´ÙÀ̾îƮȯ À¯¾Ø¹ÌÇÑÀÇ¿ø 12 1,196 2023-03-20
937 â¿ø ¸¶»ê»êÈĺ¸¾à Çѹ泻°úÀü¹®ÀÇ °Ç°­ÇÑ È¸º¹ 14 978 2023-02-02
936 [¶óÀ²ÇÑÀÇ¿ø] º½À» ±â´Ù¸®´Â 2¿ù À̺¥Æ® 0 1,156 2023-02-02
935 ÇØ¿ÂÇÑÀÇ¿ø ¼³³¯À̺¥Æ® °øÁø´Ü °æ¿Á°í ½ÖÈ­ÅÁ ÇýÅà (~1/31) 1 898 2023-01-10
934 ÇÏÀÌÅ°ÇÑÀÇ¿ø 1¿ù À̺¥Æ® ¾È³» 0 1,052 2023-01-03
933 ¸¶ÀÌÇÃÇÑÀÇ¿ø ¿¬¸» °¨»ç À̺¥Æ® 0 1,416 2022-12-09
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷